Search Results - "Alhowimel, Mansour"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Ferric carboxymaltose solution versus iron sucrose complex in treating Iron-deficiency anemia patients with heavy uterine bleeding: A cost-efficacy study from a tertiary care hospital in the Kingdom of Saudi Arabia by Ayman Hejazi, Omneya Mohamed, Mansour Alhowimel, Maysoun AlAdham

    Published in Journal of Applied Hematology (01-01-2021)
    “…BACKGROUND: Heavy uterine bleeding (HUB) affects 4.0%–51.6% of women and is responsible for the high prevalence of iron-deficiency anemia (IDA). Ferric…”
    Get full text
    Journal Article
  2. 2

    Real-World Impact of Switching From Insulin Glargine (Lantus®) to Basaglar® and Potential Cost Saving in a Large Public Healthcare System in Saudi Arabia by AlRuthia, Yazed, Bahari, Ohud H., Alghnam, Suliman, Alrumaih, Ali M., Asiri, Hassan, Alshammari, Mohammed, Alhowimel, Mansour, Al-Abdulkarim, Hana A.

    Published in Frontiers in public health (13-06-2022)
    “…Background The advent of Basaglar ® , which is a biosimilar insulin glargine formulation for Lantus ® has brought hope that it will result in similar outcomes…”
    Get full text
    Journal Article
  3. 3

    Fixed dose combinations: A formulary decision guide by Abu Esba, Laila Carolina, Yousef, Consuela, Ismail, Sherine, Halim, Murtada, Almodaimegh, Hind, Al-Abdulkarim, Hana Abdullah, Alhowimel, Mansour

    Published in Health policy and technology (01-06-2021)
    “…•Fixed-dose combinations (FDCs) are marketed with the promise of optimum patient adherence, improvement in the disease management and lower cost. P&T decision…”
    Get full text
    Journal Article
  4. 4
  5. 5